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Abstract
We have previously demonstrated that antigens chemically coupled to the surface of liposomes consisting of unsaturated
fatty acids were cross-presented by antigen-presenting cells (APCs) to CD8
+ T cells, and that this process resulted in the
induction of antigen-specific cytotoxic T lymphocytes. In the present study, the mechanism by which the liposome-coupled
antigens were cross-presented to CD8
+ T cells by APCs was investigated. Confocal laser scanning microscopic analysis
demonstrated that antigens coupled to the surface of unsaturated-fatty-acid-based liposomes received processing at both
MHC class I and class II compartments, while most of the antigens coupled to the surface of saturated-fatty-acid-based
liposomes received processing at the class II compartment. In addition, flow cytometric analysis demonstrated that antigens
coupled to the surface of unsaturated-fatty-acid-liposomes were taken up by APCs even in a 4uC environment; this was not
true of saturated-fatty-acid-liposomes. When two kinds of inhibitors, dimethylamiloride (DMA) and cytochalasin B, which
inhibit pinocytosis and phagocytosis by APCs, respectively, were added to the culture of APCs prior to the antigen pulse,
DMA but not cytochalasin B significantly reduced uptake of liposome-coupled antigens. Further analysis of intracellular
trafficking of liposomal antigens using confocal laser scanning microscopy revealed that a portion of liposome-coupled
antigens taken up by APCs were delivered to the lysosome compartment. In agreement with the reduction of antigen
uptake by APCs, antigen presentation by APCs was significantly inhibited by DMA, and resulted in the reduction of IFN-c
production by antigen-specific CD8
+ T cells. These results suggest that antigens coupled to the surface of liposomes
consisting of unsaturated fatty acids might be pinocytosed by APCs, loaded onto the class I MHC processing pathway, and
presented to CD8
+ T cells. Thus, these liposome-coupled antigens are expected to be applicable for the development of
vaccines that induce cellular immunity.
Citation: Tanaka Y, Taneichi M, Kasai M, Kakiuchi T, Uchida T (2010) Liposome-Coupled Antigens Are Internalized by Antigen-Presenting Cells via Pinocytosis and
Cross-Presented to CD8
+ T Cells. PLoS ONE 5(12): e15225. doi:10.1371/journal.pone.0015225
Editor: Derya Unutmaz, New York University, United States of America
Received August 3, 2010; Accepted November 1, 2010; Published December 17, 2010
Copyright:  2010 Tanaka et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan (to TU), grants-in-aid for young scientists from the Japan
Society for the Promotion of Science (21790963 to YT) and the research promotion grant from Toho University Graduate School of Medicine (No. 08-02 to YT). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: taneichi@nih.go.jp
Introduction
Vaccines have played an important role in disease prevention
and have made a substantial contribution to public health. Upon
natural infection, it is known that the host responds by inducing
both humoral and cellular immunity against the pathogen.
However, most of the currently approved vaccines work by
inducing humoral immunity [1–3]. For protection against viruses
that are highly mutable and frequently escape from antibody-
mediated immunity, such as influenza A viruses, HIV, and HCV,
humoral immunity is insufficient [4–7]. Consequently, the
development of vaccines that induce cellular immunity is critical
to novel vaccine strategies.
T lymphocytes respond to peptide fragments of protein antigens
that are displayed by MHC molecules on antigen-presenting cells
(APCs). In general, extracellular antigens are presented via MHC
class II molecules to CD4
+ T cells while intracellular antigens are
presented via MHC class I molecules to CD8
+ T cells [8,9].
However, a number of reports have demonstrated that a
significant level of crossover, so-called ‘cross-presentation’, occurs
in APCs [10–14]. Using this phenomenon, novel vaccine
preparation inducing antigen-specific CTLs that effectively
eliminate virus-infected cells is expected. The mechanisms of
cross-presentation have been studied intensively [15–17] while the
details have been left unclear. Part of the antigens taken via
phagocytosis by APCs are known to be translocated into the
cytosol and degraded by local proteases [18,19]. In another
pathway, some antigens internalized into endocytic compartments
are loaded onto MHC class I molecules [20].
We previously reported that antigens chemically coupled to the
surface of liposomes induced antigen-specific IgG but not IgE
antibody production [21,22]. In addition, antigens chemically
coupled to the surface of liposomes consisting of unsaturated fatty
acids were presented not only to CD4
+- but also to CD8
+ T cells
by APCs [23]. Since liposome-coupled antigens induce antiviral
immunity [24,25], they are expected to be applicable for the
development of viral vaccines without inducing antigen-specific
IgEs, which cause allergic reactions. In the present study, we
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15225investigated the mechanism by which the liposome-coupled
antigens were cross-presented by APCs to CD8
+ T cells.
Results
Confocal laser scanning microscopic analysis of
macrophages co-cultured with DQ-OVA-liposome
conjugates
MHC class I of macrophages were stained with red fluorescein-
labeled anti-mouse H-2D
d mAb (Fig. 1A: left column), and MHC
class II of macrophages were labeled with DM-DsRed (Fig. 1A:
right column) as described in Materials and Methods. DQ-OVA,
which exhibits green fluorescein upon proteolytic degradation, was
coupled to liposomes consisting of unsaturated (oleoyl) or saturated
(stearoyl) fatty acid, and added to the culture of macrophages.
After incubation for 2 hr, the recovered macrophages were
analyzed using confocal laser scanning microscopy. The results
shown in Fig. 1 demonstrate that DQ-OVA coupled to oleoyl
liposomes was processed at both MHC class I and class II
compartments, while most of the DQ-OVA coupled to stearoyl
liposomes was processed at the MHC class II compartment.
Differential manner of internalization by APCs of antigens
coupled to liposomes with two kinds of lipid
Alexa488-labeled OVA were coupled to liposomes and were
added to the cultures of macrophages. As shown in Fig. 2, OVA
coupled to oleoyl liposomes were internalized by APCs more
efficiently than those coupled to stearoyl liposomes at 37uC.
Interestingly, OVA coupled to oleoyl liposomes but not stearoyl
liposomes were internalized significantly by APCs even in a 4uC
environment.
Effect of inhibitors on uptake of liposome-coupled
antigens by APCs
One of two kinds of inhibitors, cytochalasin B and DMA, which
inhibit APC phagocytosis and pinocytosis of antigens, respectively,
was added to the culture of macrophages 1 hr prior to the addition
of Alexa488-OVA- or DQ-OVA-coupled oleoyl liposomes. One
hour later, flow cytometric analysis was performed. As shown in
Fig. 3, the effect of cytochalasin B on the antigen uptake and
digestion of liposome-coupled OVA by APCs was limited. On the
other hand, DMA significantly reduced both antigen uptake and
digestion of antigens by macrophages.
Localization of antigens coupled to liposomes in APCs
DQ-OVA-coupled oleoyl liposomes were added to the culture
of macrophages in which either EEA1 or LAMP-1 were co-
stained. The co-localization of the liposome-coupled antigens and
intracellular organelles in the APCs was analyzed using confocal
laser scanning microscopy. As shown in Figure 4, although most of
the DQ-OVA coupled to oleoyl liposomes was processed beyond
LAMP-1-expressing compartments (green spots), a portion of DQ-
OVA was processed at compartments expressing LAMP-1 (yellow
spots). Co-localization of EEA1-expressing compartments with
liposome-coupled-DQ-OVA was significantly less than that of
LAMP-1-expressing compartments with DQ-OVA (Fig. 4B).
T cell activation by APCs pulsed with liposomal antigen
In agreement with the results shown in Fig. 3, antigen
presentation by APCs pulsed with liposomal antigen was
significantly inhibited by DMA but not by cytochalasin B in both
CD4
+- and CD8
+ T cell responses (Fig. 5).
Discussion
In general, extracellular antigens are presented via MHC class
II molecules to CD4
+ T cells, whereas intracellular antigens are
presented via MHC class I molecules to CD8
+ T cells.
Consequently, most APCs do not present exogenous antigens via
MHC class I since exogenous antigens do not gain access to the
cytosolic compartment. Therefore, exogenous antigens usually do
not prime CTL responses in vivo. This segregation of exogenous
antigens from the class I pathway is important to prevent CTL
from killing healthy cells that have been exposed to foreign
antigens but are not infected [26]. However, there are several
exceptions to this rule, reflecting the ability of the exogenous
antigens to be delivered into the cytosolic compartments [13–17].
We have previously reported that antigens coupled to the
surface of liposomes comprised of unsaturated fatty acid are
presented to both CD4
+- and CD8
+ T cells [23]. Confocal laser
scanning microscopic analysis demonstrated that a portion of the
liposome-coupled antigens were taken up and processed beyond
the MHC class II compartment. In the present study, we
confirmed that OVA coupled to oleoyl liposomes was processed
at both the MHC class I and class II compartments (Fig. 1). Flow
cytometric analysis demonstrated that OVA coupled to oleoyl
liposomes was incorporated more efficiently by macrophages than
OVA coupled to stearoyl liposomes (Fig. 2). Furthermore, OVA
coupled to oleoyl liposomes was taken up by macrophages even in
a4 uC environment, in which antigen entry could only occur via
plasma membrane translocation. In general, antigen processing
pathways largely depend on the route of antigen uptake, and
liposomes with a certain lipid component are known to fuse with
the plasma membrane [27]. The uptake of OVA coupled to oleoyl
liposomes in a 4uC environment observed in the present study
suggested that oleoyl liposome might fuse with the plasma
membrane and thereby allow the liposome-coupled antigen direct
access to the cytosol. The role of endocytosis in the uptake of the
liposomal antigen was further examined by using specific
inhibitors for antigen uptake (Fig. 3). Cytochalasin B treatment
of APCs prior to the addition of liposomal antigen in the culture
had little effect. However, treatment of APCs with DMA
significantly reduced the uptake of liposome-coupled OVA.
Consequently, it was suggested that antigens coupled to oleoyl
liposomes might be taken up by APCs via at least two pathways,
penetration and pinocytosis. The analysis of intracellular pathways
of antigens coupled to oleoyl liposomes using confocal laser
scanning microscopy demonstrated that a portion of liposomal
antigens taken up by APC were translocated to the lysosomal
compartments expressing LAMP-1 (Fig. 4), suggesting that the
liposomal antigens processed at lysosomal compartment and
beyond lysosomal compartment might be presented to CD4/
CD8
+ T cells via MHC class II and class I, respectively. In
agreement with the results of antigen uptake shown in Fig. 3, the
treatment of splenic CD11c
+ cells with DMA significantly reduced
antigen presentation of liposomal antigens to both CD4
+- and
CD8
+ T cells as evaluated by T-cell activation (Fig. 5).
It was reported that pinocytosis and scavenger receptor-mediated
endocytosis by APC facilitate antigen presentation to CD4
+ T cells;
by contrast, mannose receptor-mediated endocytosis by APC has
been shown to facilitate antigen presentation to CD8
+ T cells [28].
However, as described in Materials and Methods, the oleoyl
liposomes used in the present study do not contain mannose.
Thus, the data in the present study demonstrated that antigens
coupled to oleoyl liposomes were internalized by APCs through
both penetration and pinocytosis. The antigens coupled to the
surface of oleoyl liposomes were processed at both MHC class I
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+- and CD8
+ T
cells. Although the detailed pathway leading to presentation to
both CD4
+- and CD8
+ T cells remains unclear, the observed
behavior of antigens coupled to oleoyl liposome in APCs seems
quite unique. Taken together, coupling of antigens to oleoyl
liposome might potentially serve as a novel method to induce both
humoral and cellular immunity.
Materials and Methods
Mice
CBF1 mice (8 weeks of age, female) were purchased from SLC
(Shizuoka, Japan). All experiments were approved (No. 208021
and 209082) by an independent animal ethics committee at
National Institute of Infectious Diseases, Tokyo, Japan.
Chemicals
All phospholipids were provided by NOF Co. (Tokyo, Japan).
Reagent grades of cholesterol were purchased from Wako Pure
Chemical (Osaka, Japan).
Antigens and reagents
Ovalbumin (OVA, Grade VII) was purchased from Sigma-
Aldrich. For the analysis of the processing of liposome-coupled
OVA by macrophages, DQ-OVA, which exhibits green fluores-
Figure 2. Uptake of liposome-coupled OVA by macrophages. Alexa-labeled OVA was coupled to either stearoyl or oleoyl liposomes and
added to the culture of cloned macrophages as described in Materials and Methods. Thirty minutes after the onset of the culture, macrophages were
recovered and analyzed using flow cytometry.
doi:10.1371/journal.pone.0015225.g002
Figure 1. Confocal laser scanning microscopic analysis of macrophages co-cultured with DQ-OVA-liposome conjugates. A, DQ-OVA
was coupled to either stearoyl or oleoyl liposomes and added to the culture of cloned macrophages expressing DM-DsRed (class II) or labeled with
red fluorescein (class I), as described in Materials and Methods. Two hours after the onset of the culture, macrophages were recovered and analyzed
using confocal laser scanning microscopy. These optically merged images are representative of most cells examined by confocal microscopy. Yellow,
co-localization of green (DQ-OVA after proteolytic degradation) and red (macrophage DM or class I); cell only, macrophages without co-culture with
DQ-OVA-coupled liposomes. B, the green- and yellow-color compartments in the immunofluorescent pictures were quantified by the image analysis
software MetaMorph, as described in Materials and Methods. Ratios of the yellow to green compartments are shown. Data represent the mean values
6 SD of the images shown in Fig. 1A. Asterisk, significant (p,0.01) difference of samples.
doi:10.1371/journal.pone.0015225.g001
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Molecular Probes, Inc. Synthetic CpG ODN (5002: TCCAT-
GACGTTCTTGATGTT) was purchased from Invitrogen and
was phosphorothioate-protected to avoid nuclease-dependent
degradation.
Fluorescence labeling of OVA
OVA was labeled with fluorescence using an AlexaFluor 488
protein labeling kit (Invitrogen) according to the manufacturer’s
protocol.
Liposomes
Liposomes consisting of two different kinds of lipid were used in
this study. Liposomes consisting of saturated fatty acids were
composed of distearoyl phosphatidylcholine, distearoyl phospha-
tidyl ethanolamine, distearoyl phosphatidyl glycerol acid, and
cholesterol in a 4:3:2:7 molar ratio (stearoyl liposomes), and
liposomes consisting of unsaturated fatty acids were composed of
dioleoyl phosphatidylcholine, dioleoyl phosphatidyl ethanolamine,
dioleoyl phosphatidyl glycerol acid, and cholesterol in a 4:3:2:7
molar ratio (oleoyl liposomes). The crude liposome solution was
passed through a membrane filter (nucleopore polycarbonate
filter, Coster) with a pore size of 0.2 mm.
Coupling of OVA to liposomes
Liposomal conjugates withplain OVA, Alexa-labeledOVA, or
DQ-OVA were prepared essentially in the same way as described
previously [22]. Briefly, to a mixture of 90 mg of liposomes and
6 mg of OVA in 2.5 ml phosphate buffer (pH 7.2), 0.5 ml of
2.5% glutaraldehyde solution was added in dropwise fashion.
The mixture was stirred gently for 1 h at 37uC, and then 0.5 ml
of 3 M glycine-NaOH (pH 7.2) was added to block excess
aldehyde groups. This was followed by incubation overnight at
4uC. The liposome-coupled OVA and uncoupled OVA in the
resulting solution were separated using CL-4B column chroma-
tography (Pharmacia). The amount of lipid in the liposomal
fraction was measured using a phospholipid content assay kit
(Wako Pure Chemical). The OVA-liposome solution was
adjusted to 10 mg lipid/ml in PBS, sterile-filtered using a
Millex-HA syringe filter unit (0.45 mm, Millipore), and kept at
4uCu n t i lu s e .
Quantification of OVA coupled to liposome
For the measurement of OVA coupled to liposome, radio-
labeled OVA (methyl-
14C; purchased from New England
Nuclear) was mixed with cold OVA and used for coupling
with liposome and for determining the calibration curve. The
Figure 3. Influence of inhibitors for uptake of OVA coupled to oleoyl liposomes by macrophages. Alexa- or DQ-labeled OVA was
coupled to oleoyl liposomes and added to the culture of macrophages as described in Materials and Methods. Treatment of macrophages with
cytochalasin B or DMA was done 60 minutes prior to the addition of OVA-liposome conjugates.
doi:10.1371/journal.pone.0015225.g003
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counted using a calibration curve. The amounts of OVA
coupled to stearoyl and oleoyl liposomes were 47.0 and
46.8 mg/mg lipid, respectively.
Immunization
Mice were immunized subcutaneously (s.c.) with the OVA-
liposome conjugate at a dose of 1 mg lipid/100 ml/mouse in the
presence of 5 mg/mouse CpG.
Cloned macrophage hybridoma
Macrophage hybridoma clone 39, obtained from the fusion of
splenic adherent cells from CKB mice and P388D1 [29], was used.
Construction and expression of the fusion protein,
DM-DsRed, in macrophage clone 39
The DNA fragment coding the full-length H2-DMb2 [30] was
amplified by PCR with two primers (59-ATGGCTGCACT-
CTGGCTGCTGCTGCTGGT-39 and 59-GATGCCGTCCT-
Figure 4. Intracellular localization of liposomal antigens taken up by macrophages. A, DQ-OVA was coupled to oleoyl liposomes and
added to the culture of cloned macrophages of which endosomal marker EEA1-positive compartments, or lysosomal marker LAMP-1-positive
compartments were stained as described in Materials and Methods. Two hours after the onset of the culture, macrophages were recovered and
analyzed using confocal laser scanning microscopy. These optically merged images are representative of most cells examined by confocal
microscopy. Yellow, co-localization of green (DQ-OVA after proteolytic degradation) and red (macrophage EEA1 or LAMP-1); cell only, macrophages
without co-culture with DQ-OVA liposomes. B, the green- and yellow-color compartments in the immunofluorescent pictures were quantified by the
image analysis software MetaMorph, as described in Materials and Methods. Ratios of the yellow to green compartments are shown. Data represent
the mean values 6 SD of the images shown in Fig, 4A. Asterisk, significant (p,0.01) difference of samples.
doi:10.1371/journal.pone.0015225.g004
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into the CMV promoter-driven expression plasmid pDsRedN1
(BD Clontech). This construct omitted the stop codon of H2-
DMb2 and encoded the H2-DMb2 fused with DsRed. The cloned
plasmid DNA was transfected to macrophage hybridoma clone 39
with Effectene transfection reagent (Qiagen) according to the
manufacturer’s protocol. During the transfection to clone 39, the
medium containing cDNA and the transfection reagent was
replaced with fresh medium after an 8-h transfection, and then
clone 39 was cultured for 40 h. To obtain stable cell lines, clone 39
was passaged at 1:5 into RPMI 1640 containing 10% FCS with
50 mg/ml geneticin (G-418; Sigma-Aldrich). Cells showing the
best fluorescence were selected using a FACS Vantage cell sorter
(BD Bioscience). After cell sorting, clone 39 expressing DM-DsRed
was cultured in RPMI 1640 containing 10% FCS with 200 mg/ml
geneticin.
Flow cytometry
To investigate the capture of OVA-liposome conjugates by
macrophages, macrophage clone 39 was incubated for 30 min at
4uCo r3 7 uC in the presence of fluorescence-labeled OVA-
liposome conjugates that contained a final concentration of 4 mg/
ml OVA. After the incubation, cells were washed with ice-cold
PBS. In the case of using Alexa-labeled OVA-liposome conjugates,
cells were then incubated with 1.2 mg/ml trypan-blue for 5 min at
4uC to block the fluorescence of Alexa-OVA attached to the cell
surface. After the cells were washed, they were analyzed on a
FACS Caliber flow cytometer (BD Bioscience). The histograms of
fluorescence distribution were plotted as the number of cells versus
fluorescence intensity on a logarithmic scale.
Confocal laser scanning microscopy
To investigate the localization of OVA-liposome conjugates by
macrophages, macrophage clone 39 or DM-DsRed-expressing
cloned macrophage 39 was cultured for 18 h at 37uC on 8-hole
heavy Teflon-coated slides (Bokusui Brown) and was then
incubated with DQ-OVA-liposome conjugates, prepared using
oleoyl or stearoyl liposomes, for 2 h at 37uC. The slides were then
washed with MEM and fixed with 4% paraformaldehyde in PBS
for 10 min at room temperature. After fixation, they were
incubated for 10 min in 0.1 M glycine-HCl (pH 7.0) to block
the remaining aldehyde residue. They were then washed two times
in PBS. After washing, the slides were sealed with PBS:glycerin
(1:9) and analyzed under an LSM510 confocal laser scanning
microscope system (Zeiss). For analysis of co-localization of OVA
and MHC class I, early endosomal antigen 1 (EEA1) or lysosomal-
associated membrane protein-1 (LAMP-1) after blocking of the
remaining aldehyde residue, cloned macrophage 39 was subse-
quently permeabilized with 0.05% saponin-TBS for 10 min at
room temperature. After being washed twice with PBS, they were
reacted with biotin-conjugated mouse anti-mouse H-2D
d mAb
(34-2-12, 10 mg/ml; BD Biosciences), goat anti-mouse EEA1
Figure 5. IFN-c production by splenic CD4/CD8
+ T cells of mice immunized with OVA after co-culture with CD11c
+ cells pulsed with
OVA coupled to oleoyl liposomes. Splenic CD4/CD8
+ T cells were taken from mice immunized with OVA and were cultured with CD11c
+ cells
pulsed with OVA coupled to oleoyl liposomes with or without inhibitors as described in Materials and Methods. IFN-c production of T cells in the
supernatants in the absence of inhibitors was normalized to 100%. Data represent the mean values 6 SD of triplicate culture. Asterisk, significant
(p,0.01) difference as compared with the ‘no inhibitor’ group.
doi:10.1371/journal.pone.0015225.g005
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rat anti-mouse LAMP-1 monoclonal antibody (1D4B, 1 mg/ml;
Santa Cruz Biotechnology) for 18 h at 4uC. After being washed
three times with TBS, they were reacted with Alexa 546-
conjugated streptavidin (1:200 diluted; Invitorogen) to detect
MHC class I, Alexa Fluor 568-labeled Ab (rabbit anti-goat IgG,
10 mg/ml; Invitrogen) to detect EEA1 or Alexa Fluor 568-labeled
Ab (goat anti-rat IgG, 10 mg/ml; Invitrogen) to detect LAMP-1 for
4 h at room temperature. They were then washed two times in
TBS. After the washing, the slides were sealed with PBS:glycerin
(1:9) and analyzed under an LSM510 confocal laser scanning
microscope system (Zeiss).
Quantification of immunofluorescent pictures and
statistics
Quantification of confocal image analysis was done by single
cell identification using the image analysis software MetaMorph
(Molecular Devices Co., Tokyo, Japan), and the relative
fluorescence intensity of green, red, and yellow pixels was assessed.
The relative fluorescence intensity of all individual colors was then
expressed as percent of the total fluorescence intensity. p values
were calculated by the Student’s t test with two-tailed distribution
and two-sample unequal variance parameters.
Inhibition Studies of Antigen Uptake
In the case of inhibition studies, cloned macrophage 39 or
CD11c
+ cells were incubated with indicated inhibitors 60 min
before and throughout the antigen pulse. Cytochalasin B [31] and
DMA [28] were purchased from Sigma.
Preparation of CD11c
+ cells and CD4
+- and CD8
+ T cells
CD11c
+ spleen cells of naı ¨ve mice and CD4
+ T and CD8
+ T
spleen cells of mice immunized with OVA-liposome conjugates
were prepared with the magnetic cell sorter system MACS,
according to the manufacturer’s protocol using anti-CD11c, anti-
CD4 and anti-CD8 antibody-coated microbeads (Miltenyi Biotec).
Culture of CD4
+- and CD8
+ T cells with CD11c
+ cells
pulsed with OVA
CD11c
+ cells were incubated with or without the indicated
inhibitors for 60 min in a 24-well plate prior to the addition of
OVA-liposome conjugates made using oleoyl liposomes. The final
concentration of OVA-liposome added to the macrophage culture
was 500 mg lipid/ml, which included 24 mg OVA. After 60
minutes’ incubation, CD11c
+ cells were washed 3 times in ice-cold
medium and 2610
5 cells were co-cultured with 5610
5 CD4
+ T
cells or CD8
+ T cells, in a 48-well plate. A preliminary experiment
showed that the optimal culture period in the above culture
condition was 2 days for IFN-c production by CD4
+ T cells and 5
days for IFN-c production by CD8
+ T cells. After incubation in a
CO2 incubator for 2 or 5 days, the culture supernatants were
collected and assayed for IFN-c.
IFN-c Assay
IFN-c in the culture supernatants was measured using the
Biotrak mouse ELISA system (GE Healthcare). All test samples
were assayed in duplicate, and the SD in each test was always
,5% of the mean value.
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